Prometheus Biosciences, Inc. is a clinical-stage biotechnology company that focuses on developing novel therapeutic and diagnostic products for the treatment of immune-mediated diseases through a precision medicine approach. The company's key platform, Prometheus360™, uses machine learning-based analytics to identify novel therapeutic targets. Our team worked with Prometheus Biosciences with the goal of delivering patient value through digital media. In addition to supporting their marketing team, we developed a campaign and media strategy around the Monitr® Crohn’s Disease Test. Monitr® is a non-invasive, blood-based test designed to monitor inflammation in patients with Crohn's disease and provides clinicians with a quantitative measure of inflammation by assessing certain biomarkers that are indicative of disease activity.